Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.50p
   
  • Change Today:
    -0.100p
  • 52 Week High: 64.80
  • 52 Week Low: 31.60
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 3,164
  • Market Cap: £348.66m
  • RiskGrade: 119
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 (23.05) 4.28p 12.4 n/a -33% 1.78p 3.4%
31-Dec-23 180.68 (48.80) 4.54p 8.9 1.5 +6% n/a 0.0%
31-Dec-24 178.84 (14.46) 4.32p 10.6 n/a -5% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 200.75 41.16 4.99p 13.0 0.8 +15% n/a 0.0%
31-Dec-26 210.82 44.50 5.59p 11.6 1.0 +12% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 17.14 8.92 13.21 1.13

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.50p
Change Today -0.100p
% Change -0.15 %
52 Week High 64.80
52 Week Low 31.60
Volume 3,164
Shares Issued 540.57m
Market Cap £348.66m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 09-May-2025

Time Volume / Share Price
09:30 1 @ 64.52p
09:21 1 @ 64.52p
09:19 1 @ 64.52p
09:17 1 @ 64.52p
09:15 1 @ 64.52p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page